Clinical Trial Update: Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant quadruple chemotherapy (Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin) before radical cystectomy in locally advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urethral Cancer
• Urothelial Cancer of the Renal Pelvis
• Urothelial Cancer of the Ureter

Drugs mentioned

• CISPLATIN (cisplatin)
• Doxorubicin (doxorubicin)
• Gemcitabine (Gemcitabine)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: COMPLETED